|
End-of-day quote
Shanghai S.E.
2026-08-21
|
5-day change | 1st Jan Change | ||
| 23.56 CNY | -5.15% |
|
-2.68% | -11.06% |
| 08-14 | Fosun Pharma Starts Phase Two Trial for COPD Drug | MT |
| 08-09 | Fosun Pharma Secures China Approval for Two Drugs | MT |
Chart: Technical Analysis
Stock exchange
Shanghai S.E.
600196 23.56 ¥
-5.15%
1.44B
¥
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Shanghai S.E.
| 600196 | 23.56CNY | -5.15% | 1.44B ¥ | |
Hong Kong S.E.
| 2196 | 17.37HKD | -2.96% | 86.48M $ | |
Boerse Muenchen
| 08HH | 1.932EUR | -1.78% | 1.06K € | |
OTC Markets
| SFOSF | 2.200USD | +3.77% | 946 $ | |
Tradegate
| 08HH | 1.910EUR | -1.32% | 101.26 € | |
Börse Stuttgart
| 08HH | 1.880EUR | -1.23% | 0 € | |
Deutsche Boerse AG
| 08HH | 1.869EUR | -2.53% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bearish |
| Resistance | 24.84 | 27.07 | 25.81 |
| Spread/Res. | -5.15% | -12.97% | -8.72% |
| Spread/Supp. | +4.16% | +11.08% | +11.08% |
| Support | 22.62 | 21.21 | 21.21 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 600196 Stock
- Charts Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions

















